2024-03-01 2025-02-28 false Capium Accounts Production 1.1 12454780 2024-03-01 2025-02-28 12454780 bus:AbridgedAccounts 2024-03-01 2025-02-28 12454780 bus:FRS102 2024-03-01 2025-02-28 12454780 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 12454780 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 12454780 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 12454780 2024-03-01 2025-02-28 12454780 2025-02-28 12454780 bus:RegisteredOffice 2024-03-01 2025-02-28 12454780 core:WithinOneYear 2025-02-28 12454780 core:AfterOneYear 2025-02-28 12454780 1 2024-03-01 2025-02-28 12454780 bus:Director1 2024-03-01 2025-02-28 12454780 bus:Director1 2025-02-28 12454780 bus:Director1 2023-03-01 2024-02-29 12454780 bus:Director2 2024-03-01 2025-02-28 12454780 bus:Director2 2025-02-28 12454780 bus:Director2 2023-03-01 2024-02-29 12454780 2023-03-01 12454780 bus:LeadAgentIfApplicable 2024-03-01 2025-02-28 12454780 2023-03-01 2024-02-29 12454780 2024-02-29 12454780 core:WithinOneYear 2024-02-29 12454780 core:AfterOneYear 2024-02-29 12454780 bus:EntityAccountantsOrAuditors 2023-03-01 2024-02-29 12454780 core:LandBuildings 2024-03-01 2025-02-28 12454780 core:LandBuildings 2025-02-28 12454780 core:LandBuildings 2024-02-29 12454780 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-02-28 12454780 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-02-29 12454780 core:NetGoodwill 2024-03-01 2025-02-28 12454780 core:NetGoodwill 2025-02-28 12454780 core:NetGoodwill 2024-02-29 12454780 core:CostValuation core:Non-currentFinancialInstruments 2025-02-28 12454780 core:CostValuation core:Non-currentFinancialInstruments 2024-02-29 12454780 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-02-28 12454780 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-02-28 12454780 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-02-28 12454780 core:Non-currentFinancialInstruments 2025-02-28 12454780 core:Non-currentFinancialInstruments 2024-02-29 12454780 core:ShareCapital 2025-02-28 12454780 core:ShareCapital 2024-02-29 12454780 core:RetainedEarningsAccumulatedLosses 2025-02-28 12454780 core:RetainedEarningsAccumulatedLosses 2024-02-29 12454780 dpl:Item1 2024-03-01 12454780 dpl:Item1 2025-02-28 12454780 dpl:Item1 2023-03-01 12454780 dpl:Item1 2024-02-29 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12454780
England and Wales
MAZIN HEALTHCARE LIMITED
Abridged Accounts
Period of accounts Start date: 01 March 2024 End date: 28 February 2025

MAZIN HEALTHCARE LIMITED Contents Page For the year ended 28 February 2025
Accountants' report | 1
Statement of financial position | 2
Notes to the financial statements | 3

MAZIN HEALTHCARE LIMITED Accountants' Report For the year ended 28 February 2025
Accountant’s report You consider that the company is exempt from an audit for the year ended 28 February 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. Myrtle Gund Ltd 28 February 2025 .................................................... Myrtle Gund Ltd 248 Lockwood Road Huddersfield HD1 3TG 04 December 2025 1

MAZIN HEALTHCARE LIMITED Statement of Financial Position As at 28 February 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Intangible fixed assets | 3 | 85,000 |  | 90,000
Tangible fixed assets | 4 | 252,000 |  | 252,000
|  | 337,000 |  | 342,000
Current assets |  |  |
Stocks |  | 16,400 |  | 16,400
Debtors |  | 82,142 |  | 68,526
Cash at bank and in hand |  | 12,596 |  | 27,462
|  | 111,138 |  | 112,388
Creditors: amount falling due within one year |  | (119,758) |  | (123,097)
Net current assets |  | (8,620) |  | (10,709)
Total assets less current liabilities |  | 328,380 |  | 331,291
Creditors: amount falling due after more than one year |  | (240,665) |  | (275,585)
Net assets |  | 87,715 |  | 55,706
Capital and reserves |  |  |
Called up share capital |  | 150 |  | 150
Profit and loss account |  | 87,565 |  | 55,556
Shareholders' funds |  | 87,715 |  | 55,706
For the year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the board of directors on 04 December 2025 and were signed on its behalf by:
------------------------------- Noshad Akhtar Director
2

MAZIN HEALTHCARE LIMITED Notes to the Abridged Financial Statements For the year ended 28 February 2025
General Information MAZIN HEALTHCARE LIMITED is a private company, limited by shares, registered in England and Wales, registration number 12454780, registration address Sale Pharmacy, 2 Eastway , Sale, M33 4DX. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company.
2. | Average number of employees Average number of employees during the year was 3 (2024 : 3).
3. | Intangible fixed assets
Cost | Goodwill |  | Total
| £ |  | £
At 01 March 2024 | 100,000 |  | 100,000
Additions | - |  | -
Disposals | - |  | -
At 28 February 2025 | 100,000 |  | 100,000
Amortisation
At 01 March 2024 | 10,000 |  | 10,000
Charge for year | 5,000 |  | 5,000
On disposals | - |  | -
At 28 February 2025 | 15,000 |  | 15,000
Net book values
At 28 February 2025 | 85,000 |  | 85,000
At 29 February 2024 | 90,000 |  | 90,000
4. | Tangible fixed assets
Cost or valuation | Land and Buildings |  | Total
| £ |  | £
At 01 March 2024 | 252,000 |  | 252,000
Additions | - |  | -
Disposals | - |  | -
At 28 February 2025 | 252,000 |  | 252,000
Depreciation
At 01 March 2024 | - |  | -
Charge for year | - |  | -
On disposals | - |  | -
At 28 February 2025 | - |  | -
Net book values
Closing balance as at 28 February 2025 | 252,000 |  | 252,000
Opening balance as at 01 March 2024 | 252,000 |  | 252,000
3